LataMed AI Corp. (OTC: LMED) announced that development of its mobile healthcare application has entered its final stage, with the company completing testing, optimization, and deployment preparations ahead of planned availability through the Apple App Store and Google Play. The app is expected to be submitted for distribution in the coming weeks, subject to platform review, and will serve as a primary mobile access point to LataMed AI's digital healthcare ecosystem.
The significance of this milestone lies in the company's strategic focus on Latin America, where smartphones are often the primary means of accessing digital services. By launching on both major mobile marketplaces, LataMed AI aims to provide a more direct and accessible way for users to interact with its developing healthcare platform, which is designed to connect patients, healthcare professionals, pharmacies, insurers, and other stakeholders.
Dr. Kevin Rodan Levy, CEO of LataMed AI, emphasized the importance of mobile availability: "Mobile availability is important because it provides a direct connection between users and the digital healthcare ecosystem we are building. Our objective is to create a platform that is practical, accessible and capable of expanding as we continue introducing additional healthcare services and artificial intelligence-supported tools."
The app is expected to include patient-facing tools, healthcare-provider interaction, digital communications, and access to medical information, with future functionality planned to integrate the company's AI platforms, including CardioAI, PulmoAI, and NeuroAI. These AI-supported technologies are part of LataMed AI's broader strategy to improve healthcare delivery in the region.
This transition from development to deployment represents a critical step for the company as it moves its technology from concept to user-facing infrastructure. The mobile app will provide a scalable foundation for introducing additional features over time, enhancing the company's ability to support a more connected healthcare experience.
LataMed AI believes that mobile accessibility is particularly important in Latin America, where smartphone penetration is high and many individuals rely on mobile devices for digital services. The app's availability on both Apple App Store and Google Play is intended to maximize reach and convenience for users.
The company plans to continue evaluating additional functionality and platform integrations following the initial release, with updates expected as milestones are completed. For more information, visit https://latamed.ai or review the company's filings with the SEC at www.sec.gov.
